CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-06-30 | KNOTT DAVID M 10% owner | Sale | −45,600 | $2.45 | $112K | 1,094,400 |
| 2009-06-30 | KNOTT DAVID M 10% owner | Sale | −44,200 | $2.45 | $108K | 1,739,953 |
| 2009-06-30 | KNOTT DAVID M 10% owner | Sale | −200 | $2.45 | $490 | 69,900 |
| 2009-06-29 | KNOTT DAVID M 10% owner | Sale | −55,500 | $2.52 | $140K | 1,140,000 |
| 2009-06-29 | KNOTT DAVID M 10% owner | Sale | −53,800 | $2.52 | $136K | 1,784,153 |
| 2009-06-29 | KNOTT DAVID M 10% owner | Sale | −300 | $2.52 | $756 | 70,100 |
| 2009-01-12 | KNOTT DAVID M 10% owner | Purchase | +58,500 | $3.84 | $225K | 139,800 |
Page 1 of 1 · 7 trades